Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
**Lot certified by HPLC certificate of analysis exceeding 99%, mass spectrometry confirming theoretical molecular weight (BPC-157: 1419.53 Da / TB-500 fragment: supplier-dependent, full thymosin beta-4: 4963 Da), cold chain maintained from synthesis to delivery.** Unique dual-lyophilized vial, two-minute reconstitution, aliquoting supported to extend functional shelf life
While large-scale randomized trials in MCAS are limited, case-report literature describes improvement in patients with overlapping conditions such as MCAS and severe postural orthostatic tachycardia syndrome (POTS) when naltrexone was included as part of a comprehensive care plan
Manufactured using a lyophilization process to help preserve peptide stability during storage and transport, KLOW is intended exclusively for research and laboratory use and is not intended for human or veterinary use
Thus, GSTO1 is an attractive pharmacological target, for which, there is a need for potent and selective inhibitors
The result is a product that reflects careful craftsmanship and transparency
